Insider Profile
Elford, Sara
2
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Mar 31, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Mar 31, 2026 $RX
BioSyent Inc.
Exercise Buy 343 $14.42 $5K 63
Mar 31, 2026 $RX
BioSyent Inc.
Exercise Sell 686 63
Dec 31, 2025 $RX
BioSyent Inc.
Plan / DRIP Buy 116 $11.82 $1K 63
Dec 31, 2025 $RX
BioSyent Inc.
Plan / DRIP Buy 101 $11.82 $1K 63
Dec 31, 2025 $RX
BioSyent Inc.
Exercise Buy 263 $12.73 $3K 63
Dec 31, 2025 $RX
BioSyent Inc.
Exercise Sell 526 63
Sep 30, 2025 $RX
BioSyent Inc.
Exercise Buy 262 $11.54 $3K 63
Sep 30, 2025 $RX
BioSyent Inc.
Exercise Sell 524 63
Jun 30, 2025 $RX
BioSyent Inc.
Exercise Sell 522 63
Jun 30, 2025 $RX
BioSyent Inc.
Exercise Buy 261 $11.80 $3K 63
Mar 31, 2025 $RX
BioSyent Inc.
Exercise Sell 520 63
Mar 31, 2025 $RX
BioSyent Inc.
Exercise Buy 260 $11.15 $3K 63
Dec 31, 2024 $RX
BioSyent Inc.
Exercise Sell 590 63
Dec 31, 2024 $RX
BioSyent Inc.
Plan / DRIP Buy 143 $8.91 $1K 63
Dec 31, 2024 $RX
BioSyent Inc.
Exercise Buy 295 $11.00 $3K 63
Nov 19, 2024 $BQE
BQE Water Inc.
Exercise Sell 1,500
Nov 19, 2024 $BQE
BQE Water Inc.
Exercise Buy 1,500 $8.75 $13K
Sep 30, 2024 $RX
BioSyent Inc.
Exercise Buy 294 $10.71 $3K 63
Sep 30, 2024 $RX
BioSyent Inc.
Exercise Sell 588 63
Jul 02, 2024 $RX
BioSyent Inc.
Exercise Buy 293 $10.00 $3K 63
Jul 02, 2024 $RX
BioSyent Inc.
Exercise Sell 586 63
Apr 01, 2024 $RX
BioSyent Inc.
Exercise Sell 583 63
Apr 01, 2024 $RX
BioSyent Inc.
Exercise Buy 291 $8.69 $3K 63
Mar 27, 2024 $RX
BioSyent Inc.
Comp. Grant Buy 2,385 63
Jan 02, 2024 $RX
BioSyent Inc.
Exercise Sell 2,133 63
Jan 02, 2024 $RX
BioSyent Inc.
Exercise Buy 1,066 $8.95 $10K 63
Dec 31, 2023 $RX
BioSyent Inc.
Plan / DRIP Buy 245 $7.52 $2K 63
Oct 02, 2023 $RX
BioSyent Inc.
Exercise Buy 1,061 $7.86 $8K 63
Oct 02, 2023 $RX
BioSyent Inc.
Exercise Sell 2,123 63
Dec 31, 2022 $RX
BioSyent Inc.
Plan / DRIP Buy 71 $7.07 $502 63
Mar 31, 2022 $RX
BioSyent Inc.
Comp. Grant Buy 1,980 63
Mar 19, 2021 $RX
BioSyent Inc.
Comp. Grant Buy 2,260 63
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.